Cargando…
A chemical screen for modulators of mRNA translation identifies a distinct mechanism of toxicity for sphingosine kinase inhibitors
We here conducted an image-based chemical screen to evaluate how medically approved drugs, as well as drugs that are currently under development, influence overall translation levels. None of the compounds up-regulated translation, which could be due to the screen being performed in cancer cells gro...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183993/ https://www.ncbi.nlm.nih.gov/pubmed/34033645 http://dx.doi.org/10.1371/journal.pbio.3001263 |
_version_ | 1783704498677481472 |
---|---|
author | Corman, Alba Kanellis, Dimitris C. Michalska, Patrycja Häggblad, Maria Lafarga, Vanesa Bartek, Jiri Carreras-Puigvert, Jordi Fernandez-Capetillo, Oscar |
author_facet | Corman, Alba Kanellis, Dimitris C. Michalska, Patrycja Häggblad, Maria Lafarga, Vanesa Bartek, Jiri Carreras-Puigvert, Jordi Fernandez-Capetillo, Oscar |
author_sort | Corman, Alba |
collection | PubMed |
description | We here conducted an image-based chemical screen to evaluate how medically approved drugs, as well as drugs that are currently under development, influence overall translation levels. None of the compounds up-regulated translation, which could be due to the screen being performed in cancer cells grown in full media where translation is already present at very high levels. Regarding translation down-regulators, and consistent with current knowledge, inhibitors of the mechanistic target of rapamycin (mTOR) signaling pathway were the most represented class. In addition, we identified that inhibitors of sphingosine kinases (SPHKs) also reduce mRNA translation levels independently of mTOR. Mechanistically, this is explained by an effect of the compounds on the membranes of the endoplasmic reticulum (ER), which activates the integrated stress response (ISR) and contributes to the toxicity of SPHK inhibitors. Surprisingly, the toxicity and activation of the ISR triggered by 2 independent SPHK inhibitors, SKI-II and ABC294640, the latter in clinical trials, are also observed in cells lacking SPHK1 and SPHK2. In summary, our study provides a useful resource on the effects of medically used drugs on translation, identified compounds capable of reducing translation independently of mTOR and has revealed that the cytotoxic properties of SPHK inhibitors being developed as anticancer agents are independent of SPHKs. |
format | Online Article Text |
id | pubmed-8183993 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-81839932021-06-21 A chemical screen for modulators of mRNA translation identifies a distinct mechanism of toxicity for sphingosine kinase inhibitors Corman, Alba Kanellis, Dimitris C. Michalska, Patrycja Häggblad, Maria Lafarga, Vanesa Bartek, Jiri Carreras-Puigvert, Jordi Fernandez-Capetillo, Oscar PLoS Biol Research Article We here conducted an image-based chemical screen to evaluate how medically approved drugs, as well as drugs that are currently under development, influence overall translation levels. None of the compounds up-regulated translation, which could be due to the screen being performed in cancer cells grown in full media where translation is already present at very high levels. Regarding translation down-regulators, and consistent with current knowledge, inhibitors of the mechanistic target of rapamycin (mTOR) signaling pathway were the most represented class. In addition, we identified that inhibitors of sphingosine kinases (SPHKs) also reduce mRNA translation levels independently of mTOR. Mechanistically, this is explained by an effect of the compounds on the membranes of the endoplasmic reticulum (ER), which activates the integrated stress response (ISR) and contributes to the toxicity of SPHK inhibitors. Surprisingly, the toxicity and activation of the ISR triggered by 2 independent SPHK inhibitors, SKI-II and ABC294640, the latter in clinical trials, are also observed in cells lacking SPHK1 and SPHK2. In summary, our study provides a useful resource on the effects of medically used drugs on translation, identified compounds capable of reducing translation independently of mTOR and has revealed that the cytotoxic properties of SPHK inhibitors being developed as anticancer agents are independent of SPHKs. Public Library of Science 2021-05-25 /pmc/articles/PMC8183993/ /pubmed/34033645 http://dx.doi.org/10.1371/journal.pbio.3001263 Text en © 2021 Corman et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Corman, Alba Kanellis, Dimitris C. Michalska, Patrycja Häggblad, Maria Lafarga, Vanesa Bartek, Jiri Carreras-Puigvert, Jordi Fernandez-Capetillo, Oscar A chemical screen for modulators of mRNA translation identifies a distinct mechanism of toxicity for sphingosine kinase inhibitors |
title | A chemical screen for modulators of mRNA translation identifies a distinct mechanism of toxicity for sphingosine kinase inhibitors |
title_full | A chemical screen for modulators of mRNA translation identifies a distinct mechanism of toxicity for sphingosine kinase inhibitors |
title_fullStr | A chemical screen for modulators of mRNA translation identifies a distinct mechanism of toxicity for sphingosine kinase inhibitors |
title_full_unstemmed | A chemical screen for modulators of mRNA translation identifies a distinct mechanism of toxicity for sphingosine kinase inhibitors |
title_short | A chemical screen for modulators of mRNA translation identifies a distinct mechanism of toxicity for sphingosine kinase inhibitors |
title_sort | chemical screen for modulators of mrna translation identifies a distinct mechanism of toxicity for sphingosine kinase inhibitors |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183993/ https://www.ncbi.nlm.nih.gov/pubmed/34033645 http://dx.doi.org/10.1371/journal.pbio.3001263 |
work_keys_str_mv | AT cormanalba achemicalscreenformodulatorsofmrnatranslationidentifiesadistinctmechanismoftoxicityforsphingosinekinaseinhibitors AT kanellisdimitrisc achemicalscreenformodulatorsofmrnatranslationidentifiesadistinctmechanismoftoxicityforsphingosinekinaseinhibitors AT michalskapatrycja achemicalscreenformodulatorsofmrnatranslationidentifiesadistinctmechanismoftoxicityforsphingosinekinaseinhibitors AT haggbladmaria achemicalscreenformodulatorsofmrnatranslationidentifiesadistinctmechanismoftoxicityforsphingosinekinaseinhibitors AT lafargavanesa achemicalscreenformodulatorsofmrnatranslationidentifiesadistinctmechanismoftoxicityforsphingosinekinaseinhibitors AT bartekjiri achemicalscreenformodulatorsofmrnatranslationidentifiesadistinctmechanismoftoxicityforsphingosinekinaseinhibitors AT carreraspuigvertjordi achemicalscreenformodulatorsofmrnatranslationidentifiesadistinctmechanismoftoxicityforsphingosinekinaseinhibitors AT fernandezcapetillooscar achemicalscreenformodulatorsofmrnatranslationidentifiesadistinctmechanismoftoxicityforsphingosinekinaseinhibitors AT cormanalba chemicalscreenformodulatorsofmrnatranslationidentifiesadistinctmechanismoftoxicityforsphingosinekinaseinhibitors AT kanellisdimitrisc chemicalscreenformodulatorsofmrnatranslationidentifiesadistinctmechanismoftoxicityforsphingosinekinaseinhibitors AT michalskapatrycja chemicalscreenformodulatorsofmrnatranslationidentifiesadistinctmechanismoftoxicityforsphingosinekinaseinhibitors AT haggbladmaria chemicalscreenformodulatorsofmrnatranslationidentifiesadistinctmechanismoftoxicityforsphingosinekinaseinhibitors AT lafargavanesa chemicalscreenformodulatorsofmrnatranslationidentifiesadistinctmechanismoftoxicityforsphingosinekinaseinhibitors AT bartekjiri chemicalscreenformodulatorsofmrnatranslationidentifiesadistinctmechanismoftoxicityforsphingosinekinaseinhibitors AT carreraspuigvertjordi chemicalscreenformodulatorsofmrnatranslationidentifiesadistinctmechanismoftoxicityforsphingosinekinaseinhibitors AT fernandezcapetillooscar chemicalscreenformodulatorsofmrnatranslationidentifiesadistinctmechanismoftoxicityforsphingosinekinaseinhibitors |